Valneva SE

Healthcare

NASDAQ:VALN · NASDAQ Global Select

Market Cap $507.78M Beta 1.40 P/E (TTM) -2.9

$5.36 +1.23%

+$0.07 today

52W Low $5.06High $12.25

Vol 0.02M · Avg 0.09M

EPS (TTM)-$0.80

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-10.75%

Period High

$12.20

Period Low

$5.17

Latest

$5.36

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Day One Biopharmaceuticals, Inc.

DAWN

$2.22B

Iovance Biotherapeutics, Inc.

NASDAQ:IOVA

$1.46B

ArriVent BioPharma, Inc. Common Stock

NASDAQ:AVBP

$1.42B

MBX Biosciences, Inc. Common Stock

NASDAQ:MBX

$1.19B

MeiraGTx Holdings plc

NASDAQ:MGTX

$888.13M

Geron Corporation

NASDAQ:GERN

$737.75M

Replimune Group, Inc.

NASDAQ:REPL

$733.24M

Astria Therapeutics, Inc.

ATXS

$718.13M

Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

$515.41M

Arvinas, Inc.

NASDAQ:ARVN

$489.07M

What is the latest VALN filing?

The latest filing shown is 6-K dated Jun 5, 2026.

How many recent filings does VALN have?

Intrinsic Alpha currently shows 20 recent filings for VALN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.